Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 13Terminated 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 20INDUSTRY 10NIH 4NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Non-Small-Cell Lung 25Ovarian Neoplasms 23Breast Neoplasms 22Lung Neoplasms 19Lymphoma 18Carcinoma, Ovarian Epithelial 18Neoplasm Metastasis 14Colorectal Neoplasms 14Squamous Cell Carcinoma of Head and Neck 12Sarcoma 12Head and Neck Neoplasms 12Urinary Bladder Neoplasms 10Prostatic Neoplasms 10Colonic Neoplasms 10Central Nervous System Neoplasms 10Astrocytoma 10Rectal Neoplasms 9Multiple Myeloma 9Uterine Cervical Neoplasms 8Oligodendroglioma 8Mycosis Fungoides 8Fallopian Tube Neoplasms 8Adenocarcinoma of Lung 8Stomach Neoplasms 7Recurrence 7Melanoma 7Medulloblastoma 7Brain Neoplasms 7Sezary Syndrome 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6

Interventions

Radiotherapy 2Cetuximab 2Surgical Procedures, Operative 1Oxaliplatin 1Irinotecan 1Fluorouracil 1Docetaxel 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × NETWORK × Adenocarcinoma Of Esophagus × Clear all
NCT00551759 2023-07-03

Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer

Eastern Cooperative Oncology Group

Phase 2 Terminated
22 enrolled 5 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT00109850 2015-11-18

S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer

SWOG Cancer Research Network

Phase 2 Terminated
22 enrolled 9 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡